 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | recombinant viral macrophage inflammatory protein (rvMIP) / Guangzhou Suyuan Biotech
Phase classification: Efficacy and safety of aerosol inhalation of vMIP in the treatment of novel coronavirus pneumonia (COVID-19): a single arm clinical trial (EUDRACT) - Dec 5, 2023
P=N/A, N=40, Recruiting, Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology; Union Hospital, Tongji Medical College, Huazhong University of
Phase classification: P1 --> P=N/A